PharmaState Is Official Media Partner For DUPHAT 2022. Click the banner to explore more...spot_imgspot_imgspot_img

Buying process: Relevance to Pharma Sales

-

Marketing is basically Removal of Hitches (Temporary objections) between the Sales & Buying.

Buying & Selling are the most important steps in any drug’s life cycle. The more we understand the buying & selling process, the better we can make the marketing plan. And for that, we need to understand the hitches in buying & selling any drug.

Let’s see a simple buying process & then we will try to fit it into pharma product buying process.

Let’s understand with an example of Dr. X who has built a new clinic & now wants to dispense drugs in his OPD. Let’s see how he is going to use buying process. He is looking for a Lipid lowering drug (LLD) to be kept in his OPD for dispensing.

Step 1. Problem recognition: Dr. X understands that the patients of Obesity are increasing & reports usually show that there are a large no. of patients who require LLD in the prescription. The patients are of middle & higher income group who will visit his clinic for consultation. Dr. X analyzed that he needs LLD in his OPD for dispensing & also the cost of drug needs to be considered as the middle income & high income group both have their own Out of pocket spending capacities.

Problem Recognition statement from Dr. XI need a high quality LLD which is  efficacious, safe  & affordable to both high income & middle income group patients visiting the clinic.

Step 2. Information search: Dr X starts talking to drug companies to finalize the product which solves his problem recognition aspect. He searched the internet & asked companies for quotes. Also contacted a few Sales professionals of drug companies. In response to that, he received a lot of quotations with rates that varied from company to company.

Step 3. Evaluation of alternatives: Now the process to select the best LLD starts. There are a lot of factors that will work here, a few to mention are Company brand image, Other drugs from the company & their efficacy, Scientific data to support that drug efficacy & safety, usage pattern, Cost, Company credentials in terms of transparent dealing, credit period, Distributor channel, international & national share of voice for the LLD.

Step 4 & 5. Purchase decision & Purchase: After considering all these factors final decision is taken post negotiations with companies. Remember that the purchase decision is dependent on many factors & due to which the companies offering should offer the best in all attributes mentioned above in the Evaluation of alternatives. Finally, Dr X agrees to buy 2 LLD from 2 different companies. Company1, LLD1@Rs 24/- per pill & Company2, LLD2@Rs08/- per pill. Company1 is branded offering & company2 is a generic offering. Both companies agree to provide orders for 3 months as credit.

It’s not the purchase where the process stops, the last step is too crucial & should never be ignored.

Step 6. Post purchase evaluation: Dr. X starts using the drugs & measures the efficacy claimed by the companies. He finds that the safety & efficacy results of both drugs LLD1 Branded & LLD2 generic are same.

The company1 has very transparent process of billing, credit notes are settled on time & distributor supply of drugs is on time. Whereas company2 is providing credit notes which are not settled on time &  the distribution of drug is not on time. Sometimes patients are not getting the medications from the Clinic pharmacy.  Now in spite of  drug2 being cheaper & having same results, there are a few hitches that are creating a belief in Dr. X’s mind that company2 is not so good in its operations. So Dr. X starts looking out for a new company which can provide him generic version but without these hitches. Meanwhile he starts dispensing the Company1 LLD1 in his clinic.

The marketing & sales Dept. of company2 needs to analyze this Post-purchase behaviour of Dr X & must try to remove the hitches by providing the solutions for the credit notes, improper distribution & supply, Otherwise company2 is going to lose the business even when the LLD2 is efficacious & safe at par with LLD1.

Key takeaways:

  1. The sales & marketing team should design a buying process for every product & the Hitches should be removed at regular intervals because the buying process is multi-factorial.
  2. In a sales review meeting, sales & marketing teams should talk in terms of buying process steps. For example: If a new Company3 comes up in the market with LLD3 & the sales of LLD1 is impacted, the discussion between the sales team should be on the basis of analysis done on all steps of the buying process & which steps motivated Dr X to buy from company3. Post discussions, find solutions to the root cause & apply those solutions which have maximum impact.

Always remember Pareto’s Principle which says – 20% of the solutions provide 80% impact, so better be focused on those 20% solutions instead of those 80% solutions which will provide 20% impact.

Author

Dr. Satish Gupta
A Pharma-addict

PharmaState Academy
PharmaState Academy is a Learning & Development Portal which is focused on Pharmaceutical Industry training needs.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Rajib ghose on TOOLING FOR TABLETING
K. SRinivasula Reddy on Quality Agreements – PART 2
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: